Sharyn D Baker (Sharyn Baker)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Tyrosine Kinase

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Basic & clinical pharmacology & toxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas Drabison, Mike Boeckman, Yan Yang, Kevin M Huang, Peter de Bruijn, Mahesh R Nepal, Josie A Silvaroli, Anika T Chowdhury, Eric D Eisenmann, Xiaolin Cheng, Navjot Singh Pabla, Ron H J Mathijssen, Sharyn D Baker, Shuiying Hu, Alex Sparreboom, Zahra Talebi
Systematic Evaluation of Tyrosine Kinase Inhibitors as OATP1B1 Substrates Using a Competitive Counterflow Screen. Cancer research communications (2024)
Hiroto Inaba, Jolieke G van Oosterwijk, John Carl Panetta, Lie Li, Daelynn R Buelow, James S Blachly, Sheila Shurtleff, Ching-Hong Pui, Raul C Ribeiro, Jeffrey E Rubnitz, Stanley Pounds, Sharyn D Baker
Preclinical and Pilot Study of Type I FLT3 Tyrosine Kinase Inhibitor, Crenolanib, with Sorafenib in Acute Myeloid Leukemia and FLT3-Internal Tandem Duplication. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (12) (2022)
Yang Li, Yan Jin, Hanieh Taheri, Keith T Schmidt, Alice A Gibson, Stefan A J Buck, Eric D Eisenmann, Ron H J Mathijssen, William Douglas Figg, Sharyn D Baker, Alex Sparreboom, Shuiying Hu
A Metabolomics Approach for Predicting OATP1B-Type Transporter-Mediated Drug-Drug Interaction Liabilities. Pharmaceutics 14 (9) (2022)
Dominique A Garrison, Yan Jin, Zahra Talebi, Shuiying Hu, Alex Sparreboom, Sharyn D Baker, Eric D Eisenmann
Itraconazole-Induced Increases in Gilteritinib Exposure Are Mediated by CYP3A and OATP1B. Molecules (Basel, Switzerland) 27 (20) (2022)
Eric D Eisenmann, Jack C Stromatt, Sydney Fobare, Kevin M Huang, Daelynn R Buelow, Shelley J Orwick, Jae Yoon Jeon, Robert H Weber, Bill Larsen, Alice S Mims, Erin Hertlein, John C Byrd, Sharyn D Baker
TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion. Cancers 15 (1) (2022)
Eric D Eisenmann, Jack C Stromatt, Sydney Fobare, Kevin M Huang, Daelynn R Buelow, Shelley J Orwick, Jae Yoon Jeon, Robert H Weber, Bill Larsen, Alice S Mims, Erin Hertlein, John C Byrd, Sharyn D Baker
TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion. Cancers 15 (1) (2022)
Eric D Eisenmann, Dominique A Garrison, Zahra Talebi, Yan Jin, Josie A Silvaroli, Jin-Gyu Kim, Alex Sparreboom, Michael R Savona, Alice S Mims, Sharyn D Baker
Interaction of Antifungal Drugs with CYP3A- and OATP1B-Mediated Venetoclax Elimination. Pharmaceutics 14 (4) (2022)
Deborah M Stephens, Ying Huang, Amy S Ruppert, Janek S Walker, Daniel Canfield, Casey B Cempre, Qiang Fu, Sharyn D Baker, Boyu Hu, Harsh Shah, Renee Vadeboncoeur, Kerry A Rogers, Seema A Bhat, Samantha M Jaglowski, Hank Lockman, Rosa Lapalombella, John C Byrd, Jennifer A Woyach
Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I Study. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (15) (2022)
Eric D Eisenmann, Jack C Stromatt, Sydney Fobare, Kevin M Huang, Daelynn R Buelow, Shelley J Orwick, Jae Yoon Jeon, Robert H Weber, Bill Larsen, Alice S Mims, Erin Hertlein, John C Byrd, Sharyn D Baker
TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion. Cancers 15 (1) (2022)
Daelynn R Buelow, Bhavana Bhatnagar, Shelley J Orwick, Jae Yoon Jeon, Eric D Eisenmann, Jack C Stromatt, Navjot Singh Pabla, James S Blachly, Sharyn D Baker, Bradley W Blaser
BMX kinase mediates gilteritinib resistance in FLT3-mutated AML through microenvironmental factors. Blood advances 6 (17) (2022)
Eric D Eisenmann, Jack C Stromatt, Sydney Fobare, Kevin M Huang, Daelynn R Buelow, Shelley J Orwick, Jae Yoon Jeon, Robert H Weber, Bill Larsen, Alice S Mims, Erin Hertlein, John C Byrd, Sharyn D Baker
TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion. Cancers 15 (1) (2022)
Eric D Eisenmann, Zahra Talebi, Alex Sparreboom, Sharyn D Baker
Boosting the oral bioavailability of anticancer drugs through intentional drug-drug interactions. Basic & clinical pharmacology & toxicology (2021)
Jason T Anderson, Shuiying Hu, Qiang Fu, Sharyn D Baker, Alex Sparreboom
Role of equilibrative nucleoside transporter 1 (ENT1) in the disposition of cytarabine in mice. Pharmacology research & perspectives 7 (6) (2019)